| Title | Biomedicine and Pharmacotherapy |
| Abbreviation | Biomed. Pharmacother. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q1); Pharmacology (Q1) |
| h-index | 169 |
| Overall Rank/Ranking | 1776 |
| SCImago Journal Rank (SJR) | 1.775 |
| Impact Score | 7.85 |
| Publisher | Elsevier Masson s.r.l. |
| Country | France |
| ISSN | 07533322, 19506007 |
| Best Quartile | Q1 |
| Coverage History | 1982-2025 |
| Official Website | Visit Website |
| Wikipedia Page | Visit Wikipedia |
Biomedicine & Pharmacotherapy is a multidisciplinary journal that publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.
The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.
Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.
Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers
Biomedicine and Pharmacotherapy is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Pharmacology (Q1). It is published by Elsevier Masson s.r.l.. The overall rank of Biomedicine and Pharmacotherapy is 1776. According to SCImago Journal Rank (SJR), this journal is ranked 1.775. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 169. The best quartile for this journal is Q1.
The ISSN of Biomedicine and Pharmacotherapy journal is 07533322, 19506007. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Biomedicine and Pharmacotherapy is cited by a total of 39511 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Biomedicine and Pharmacotherapy is 7.85, which is computed in 2025 as per its definition. Biomedicine and Pharmacotherapy IF is increased by a factor of 0.65 and approximate percentage change is 9.03% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Biomedicine and Pharmacotherapy is 7.85. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 7.85 |
| 2023 | 7.20 |
| 2022 | 7.76 |
| 2021 | 7.19 |
| 2020 | 6.10 |
| 2019 | 4.61 |
| 2018 | 3.86 |
| 2017 | 3.53 |
| 2016 | 3.05 |
| 2015 | 2.67 |
| 2014 | 2.37 |
Biomedicine and Pharmacotherapy has an h-index of 169. It means 169 articles of this journal have more than 169 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Biomedicine and Pharmacotherapy is 07533322, 19506007. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Biomedicine and Pharmacotherapy is 1776. According to SCImago Journal Rank (SJR), this journal is ranked 1.775. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.775 |
| 2023 | 1.493 |
| 2022 | 1.366 |
| 2021 | 1.194 |
| 2020 | 1.323 |
| 2019 | 1.050 |
| 2018 | 0.931 |
| 2017 | 0.951 |
| 2016 | 0.864 |
| 2015 | 0.810 |
| 2014 | 0.788 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1776 |
| 2023 | 2270 |
| 2022 | 2494 |
| 2021 | 3087 |
| 2020 | 2792 |
| 2019 | 4003 |
| 2018 | 4790 |
| 2017 | 4668 |
| 2016 | 5313 |
| 2015 | 5818 |
| 2014 | 5821 |
Biomedicine and Pharmacotherapy is published by Elsevier Masson s.r.l.. It's publishing house is located in France. Coverage history of this journal is as following: 1982-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The highest fee charged by this journal is 2660 USD as publication fees (article processing charges or APCs).
There is a waiver policy for these charges.
| YEAR | SUBMISSION TO FIRST DECISION (In Weeks) | SUBMISSION TO FINAL DECISION (In Weeks) |
|---|---|---|
| 2020 | 2.0 | 4.2 |
| 2019 | 2.4 | 4.6 |
| 2018 | 2.9 | 4.9 |
| 2017 | 3.2 | 5.2 |
| 2016 | 4.9 | 7.0 |
The IS0 4 standard abbreviation of Biomedicine and Pharmacotherapy is Biomed. Pharmacother.. This abbreviation ('Biomed. Pharmacother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Biomedicine and Pharmacotherapy latest impact IF is 7.85. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 7.85 (2024) and 2.37 (2014), respectively, in the last 11 years. Moreover, its average IS is 5.11 in the previous 11 years.
The Biomedicine and Pharmacotherapy has an SJR (SCImago Journal Rank) of 1.775, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.775 in 2024 and the lowest being 0.788 in 2014. Furthermore, the average SJR of the Biomedicine and Pharmacotherapy over the previous 11-year period stands at 5.11.
The latest h-index of the Biomedicine and Pharmacotherapy is 169.
The Biomedicine and Pharmacotherapy is published by the Elsevier Masson s.r.l., with its country of publication being the France.
The Biomedicine and Pharmacotherapy is currently ranked 1776 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1776 in 2024 and its lowest position of 5821 in 2014.
The standard ISO4 abbreviation for the Biomedicine and Pharmacotherapy is Biomed. Pharmacother..
Biomedicine and Pharmacotherapy is classified as a journal that the Elsevier Masson s.r.l. publishes.
The Biomedicine and Pharmacotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Biomedicine and Pharmacotherapy is assigned the following International Standard Serial Numbers (ISSN): 07533322, 19506007.
The best quartile for the Biomedicine and Pharmacotherapy is Q1 (2024).
The Biomedicine and Pharmacotherapy coverage history can be summarized as follows: 1982-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9811 | Vilnius Gediminas Technical University | 55 | 2.84 |
| Indian Journal of Plastic Surgery | journal | 30965 | Georg Thieme Verlag | 44 | 0.46 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| International Journal of Mathematical Education in Science and Technology | journal | 6477 | Taylor and Francis Ltd. | 45 | 1.82 |
| International Journal of Applied Linguistics | journal | 6655 | Wiley-Blackwell Publishing Ltd | 57 | 2.61 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10600 | Schweizerbart Science Publishers | 18 | 4.25 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18136 | Springer Medizin | 25 | 0.68 |
| Sapporo Medical Journal | journal | 29756 | Sapporo Medical University | 3 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 7.85 |
| 2023 | 7.20 |
| 2022 | 7.76 |
| 2021 | 7.19 |
| 2020 | 6.10 |
| 2019 | 4.61 |
| 2018 | 3.86 |
| 2017 | 3.53 |
| 2016 | 3.05 |
| 2015 | 2.67 |
| 2014 | 2.37 |
